Zydus, Guardant Health to co-promote Guardant360 portfolio of liquid, tissue biopsy tests across India, Nepal Ruchika Sharma2 Nov 2023 3:30 PM ISTGuardant360 is a minimally invasive liquid biopsy test that provides comprehensive genomic profiling of all solid tumours by analysing circulating...
Merck bags USFDA nod for Keytruda plus gemcitabine, cisplatin to treat Biliary Tract Cancer Ruchika Sharma2 Nov 2023 2:30 PM ISTKEYTRUDA is an anti-programmed death receptor-1 (PD-1) therapy that works by increasing the ability of the body's immune system to help detect and...
Natco Pharma Pharmacovigilance department successfully completes USFDA inspection Ruchika Sharma2 Nov 2023 1:00 PM ISTHyderabad: Natco Pharma Limited has announced the successful completion of United States Food and Drug Administration’s (USFDA) inspection of the...
Pfizer hair loss drug Litfulo approved in UK Ruchika Sharma2 Nov 2023 11:30 AM ISTAlopecia areata is a condition where the immune system attacks hair follicles and causes hair to fall out, often in clumps.
Gilead's Kite, Epic Bio collaborate for development of new cancer therapies Ruchika Sharma2 Nov 2023 10:00 AM ISTUnder the terms of the agreement, Epic Bio will develop constructs for Kite-selected targets for use in CAR T-cell therapies directed to blood...
Zydus Lifesciences buys LiqMeds Group for around Rs 689 crore Ruchika Sharma1 Nov 2023 4:45 PM ISTZydus will pay an upfront consideration of GBP 68 million (around Rs 689 crore) and yearly earn-outs until 2026 depending on achievement of certain...
Lupin gets USFDA EIR for Mandideep Unit 2 manufacturing facility Ruchika Sharma1 Nov 2023 3:45 PM ISTMumbai: Global pharma major Lupin Limited has announced that the Company has received the Establishment Inspection Report (EIR) from the United States...
Novartis wins USFDA nod for Cosentyx to treat hidradenitis suppurativa in adults Ruchika Sharma1 Nov 2023 2:00 PM ISTBasel: Novartis has announced that the US Food and Drug Administration (FDA) has approved Cosentyx (secukinumab) to treat moderate to severe...
Sun Pharma reports bigger-than-expected rise in Q2 profit Ruchika Sharma1 Nov 2023 12:30 PM ISTThe company's generic version of popular cancer drug Revlimid is also a significant contributor to the total sales.
GSK enters agreement to obtain exclusive license for hepatitis B therapy to expand bepirovirsen development Ruchika Sharma1 Nov 2023 11:30 AM ISTGSK will be responsible for upfront and potential milestone-based payments to both Janssen and Arrowhead totalling approximately USD 1 billion.
Mankind Pharma net profit rises 21 percent to Rs 511 crore in Q2 Ruchika Sharma1 Nov 2023 10:00 AM ISTNew Delhi: Mankind Pharma has said its consolidated net profit increased by 21 per cent to Rs 511 crore for the second quarter ended September...
Q2 results: Pfizer reports 52.11 percent decline in net profit at Rs 148.96 crore Ruchika Sharma31 Oct 2023 3:30 PM ISTNew Delhi: Drug firm Pfizer Ltd has reported 52.11 per cent decline in net profit at Rs 148.96 crore for the second quarter ended September 2023.The...
